179 related articles for article (PubMed ID: 9811057)
1. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.
Matsuno H; Sawai T; Nezuka T; Uzuki M; Tsuji H; Nishimoto N; Yoshizaki K
Arthritis Rheum; 1998 Nov; 41(11):2014-21. PubMed ID: 9811057
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis.
Jia J; Wang C; Shi Z; Zhao J; Jia Y; Zhao-Hui Z; Li X; Chen Z; Zhu P
Rheumatology (Oxford); 2009 Jul; 48(7):721-6. PubMed ID: 19429906
[TBL] [Abstract][Full Text] [Related]
3. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells.
Ogawa Y; Ohtsuki M; Uzuki M; Sawai T; Onozawa Y; Nakayama J; Yonemura A; Kimura T; Matsuno H
Arthritis Rheum; 2003 Dec; 48(12):3350-8. PubMed ID: 14673986
[TBL] [Abstract][Full Text] [Related]
4. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
[TBL] [Abstract][Full Text] [Related]
5. Requirement of methotrexate in combination with anti-tumor necrosis factor-alpha therapy for adequate suppression of osteoclastogenesis in rheumatoid arthritis.
Matsuno H; Yoshida K; Ochiai A; Okamoto M
J Rheumatol; 2007 Dec; 34(12):2326-33. PubMed ID: 18050387
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis.
Nakazawa F; Matsuno H; Yudoh K; Katayama R; Sawai T; Uzuki M; Kimura T
J Rheumatol; 2001 Aug; 28(8):1800-8. PubMed ID: 11508582
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice.
Tanaka K; Yamamoto T; Aikawa Y; Kizawa K; Muramoto K; Matsuno H; Muraguchi A
Rheumatology (Oxford); 2003 Nov; 42(11):1365-71. PubMed ID: 12810927
[TBL] [Abstract][Full Text] [Related]
8. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
9. Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis.
Sakai K; Matsuno H; Morita I; Nezuka T; Tsuji H; Shirai T; Yonehara S; Hasunuma T; Nishioka K
Arthritis Rheum; 1998 Jul; 41(7):1251-7. PubMed ID: 9663483
[TBL] [Abstract][Full Text] [Related]
10. Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice.
Jorgensen C; Apparailly F; Canovas F; Verwaerde C; Auriault C; Jacquet C; Sany J
Arthritis Rheum; 1999 Apr; 42(4):678-85. PubMed ID: 10211881
[TBL] [Abstract][Full Text] [Related]
11. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis.
Matsuno H; Yudoh K; Uzuki M; Nakazawa F; Sawai T; Yamaguchi N; Olsen BR; Kimura T
J Rheumatol; 2002 May; 29(5):890-5. PubMed ID: 12022345
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice.
Jorgensen C; Demoly P; Noel D; Mathieu M; Piechaczyc M; Gougat C; Bousquet J; Sany J
J Rheumatol; 1997 Nov; 24(11):2076-9. PubMed ID: 9375863
[TBL] [Abstract][Full Text] [Related]
13. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis.
Klimiuk PA; Goronzy JJ; Weyand CM
J Immunol; 1999 Apr; 162(7):4293-9. PubMed ID: 10201961
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
Neidhart M; Gay RE; Gay S
Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
16. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55.
Alsalameh S; Amin RJ; Kunisch E; Jasin HE; Kinne RW
J Rheumatol; 2003 Aug; 30(8):1680-90. PubMed ID: 12913922
[TBL] [Abstract][Full Text] [Related]
17. Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice.
Sack U; Kuhn H; Ermann J; Kinne RW; Vogt S; Jungmichel D; Emmrich F
J Rheumatol; 1994 Jan; 21(1):10-6. PubMed ID: 8151561
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
19. The role of TNF-alpha in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera.
Matsuno H; Yudoh K; Katayama R; Nakazawa F; Uzuki M; Sawai T; Yonezawa T; Saeki Y; Panayi GS; Pitzalis C; Kimura T
Rheumatology (Oxford); 2002 Mar; 41(3):329-37. PubMed ID: 11934972
[TBL] [Abstract][Full Text] [Related]
20. T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization.
Koenders MI; Marijnissen RJ; Joosten LA; Abdollahi-Roodsaz S; Di Padova FE; van de Loo FA; Dulos J; van den Berg WB; Boots AM
Arthritis Rheum; 2012 Jun; 64(6):1762-70. PubMed ID: 22213107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
